中东和非洲左心室辅助装置 (LVAD) 市场，按产品类型（心脏泵、控制器、电池、电线）、治疗（移植桥接 (BTT) 治疗、目的地治疗、候选桥接 (BTC) 治疗、康复桥接 (BTR) 治疗）、年龄组（成人、儿童）、适应症（充血性心力衰竭、先天性心脏病、心肌炎、心脏骤停、家族性心律失常和心律失常、心肌病、晚期心力衰竭、其他）、代数（第二代设备、第三代设备、第一代设备）、耐用性（长期、中期、短期）、设计（轴向、离心）、脉冲类型（非脉动、脉动）、最终用户（医院、心导管实验室、专科诊所、其他）、分销渠道（直接招标、零售销售、其他）、国家（南非、沙特阿拉伯、阿联酋、埃及、以色列和中东及非洲其他地区）行业趋势及预测至 2029 年
市场分析和见解:中东和非洲左风道辅助设备市场
左心管辅助装置(LVAD)市场预计将在2022至2029年的预测期内获得市场增长. 数据桥市场研究分析认为,在2022至2029年的预测期内,市场正在增长,CAGR为7.5%,预计到2029年将达到3,384万美元. 改变生活方式的触发因素加上心血管疾病的发展和有利的补偿政策的存在等,正在推动左心风辅助装置的市场增长。
左心管辅助装置(LVAD)是用于已到达末期心脏衰竭的患者的一种泵. 左通心管辅助装置是外科植入的,它是一个运行的电池,机械泵,帮助左通心管抽出血液给其他血液. LVAD可用作接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接接
改变生活方式引发了心血管疾病的发展,从而增加了对左心管辅助装置(LVAD)产品的需求,从而改善了病人的结果并使他们能够过上更好的生活,从而成为了左心管辅助装置(LVAD)市场的驱动力。 与LVAD有关的并发症和风险,以及LVAD植入和治疗的高成本,预计会阻碍左心管辅助装置(LVAD)市场增长. 最低侵入程序增加,左口辅助装置的技术进步也增加,从而成为左口辅助装置市场的机会。 正在进行的COVID-19对LVAD植入数量产生了影响,从而减少了总的产品销售并影响到了总的市场规模,从而成为了左侧口腔辅助装置市场增长的挑战。
左侧通风辅助装置(LVAD)市场报告详细介绍了市场份额、新发展和产品管道分析、国内和地方市场参与者的影响,分析了新兴收入领域的机会、市场监管的变化、产品批准、战略决定、产品推出、地域扩张以及市场技术创新。 为了了解分析结果和左通风辅助设备(LVAD)市场假想与Data Bridge市场研究联系,
左风道辅助设备(LVAD) 市场范围和市场大小
左心管辅助装置(LVAD)市场按产品类型,治疗,年龄组,指示,生成,耐久性,设计,脉冲类型,终端用户和配送渠道分出. 不同部门之间的增长有助于你分析特殊的增长领域和接近市场的战略,并确定你的核心应用领域以及目标市场的差异。
- 根据产品类型,左心管辅助装置(LVAD)市场被分入心泵,控制器,电池和电线. 2022年,由于持续的技术进步以及越来越多的儿童使用产品临床试验,心脏泵部分预计将主导左心管辅助装置市场。
- 在治疗的基础上,左心管辅助装置(LVAD)市场被分入到桥接移植(BTT)治疗,目的地治疗,桥接竞争(BTC)治疗,桥接恢复(BTR)治疗. 2022年,由于LVAD装置的小型化以及操作技术的改进,导致存活率大幅提高,桥接到移植(BTT)治疗部分预计将占据市场主导地位.
- 根据年龄组,左心管辅助装置(LVAD)市场分为成人和儿科. 2022年,由于生活方式的改变和容易心力衰竭的老年人口不断增加,预计成人部分将主导市场.
- 根据指示,左心房辅助装置(LVAD)市场被分出为凝血性心力衰竭,先天性心病,心肌炎,心跳停止,家庭心律不全和心律不全等疾病. 2022年,由于连续流水泵的植入增加和收缩性心衰竭的流行率上升,预计收缩性心衰竭会支配市场.
- 在生成的基础上,左心管辅助装置(LVAD)市场被分出为第二代装置,第三代装置和第一代装置. 2022年,由于耐久性高,设备植入率更平和,驱动管感染率更低等原因,预计第二代设备段将主导市场.
- 在耐久性的基础上,左通口辅助装置(LVAD)市场被分割成长期,中期和短期. 2022年,由于与长期成功率相挂钩的耐用左通心管辅助装置的需求不断增长,预计长期部分将主导市场.
- 在设计的基础上,左侧通心辅助装置(LVAD)市场被分入轴和离心. 2022年,轴心部分预计将占据市场主导地位,因为这些部分在市场中被首次批准,是最常见的LVAD泵,它提高了患者的生活状况,特别是在末期心脏衰竭的患者中。
- 根据脉冲类型,左心管辅助装置(LVAD)市场被分入非脉冲和脉冲. 2022年,非脉冲部分预计将占据市场主导地位,因为这些是连续流LVAD泵并增强心脏衰竭患者的心脏功能效益. 此外,非胃泵提高了被诊断为心力衰竭的病人的锻炼能力。
- 在最终用户的基础上,左心管辅助装置市场被分割成医院、专科诊所、心脏腔实验室等。 2022年,由于市场参与者与医院之间就LVAD的持续技术进步达成战略协议,预计医院部分将主导市场. 此外,目前为患者提供高质量LVAD设备的临床试验正在推动市场增长。
- 以发售渠道为基础,将左通口辅助装置(LVAD)市场分出为直接招标,零售等. 2022年,由于直接招标以成本效益高的方式提供高质量的LVAD,预计直接招标部分将主导市场. 此外,它还允许在缩短的时间内进行易用设备采购,这也正在促进市场增长。
左风道辅助设备(LVAD)
左心管辅助装置(LVAD)市场按产品类型,治疗,年龄组,指示,生成,耐久性,设计,脉冲类型,终端用户和配送渠道分出.
左侧通风辅助装置市场报告中涵盖的国家有南非、沙特阿拉伯、美国、埃及、以色列和中东其他地区及非洲。
中东和非洲区域的心脏泵部分预计将增长,在2022至2029年的预测期间增长率最高,原因是心脏疾病发病率不断上升,并迅速发起心脏宣传运动。 由于机械循环辅助装置的植入增加,沙特阿拉伯的心脏泵部分正在主宰中东和非洲左心管辅助装置市场。
报告的国家部分还介绍了影响市场的因素和国内市场监管的变化,这些因素和变化影响到市场目前和未来的趋势。 新的销售、替代销售、国家人口统计、管制条例和进出口关税等数据点是用来预测个别国家市场情况的一些主要指针。 此外,考虑到全球品牌的存在和可得性及其由于来自当地和国内品牌的大规模或稀缺竞争而面临的挑战,在对国家数据进行预测分析的同时,还考虑了销售渠道的影响。
老年人口不断增加,心脏病发病率也不断上升,这推动了左外道辅助器具市场的增长。
左侧通风辅助装置(LVAD)市场也为各国特定市场的增长提供了详细的市场分析. 此外,报告还详细介绍了市场参与者的战略及其地域存在。 现有2011至2020年历史时期的数据。
竞争性景观和左风道辅助设备(LVAD)市场份额分析
左心管辅助装置(LVAD)市场竞争景观提供了由竞争对手提供的细节. 详细情况包括:公司概况,公司财务,创收,市场潜力,研发投资,新市场举措,生产地和设施,公司优势和弱点,产品推出,产品试验管线,产品审批,专利,产品宽度和广度,应用优势,技术命脉曲线等. 上述数据点仅与公司与左口辅助装置市场有关的重点有关。
以左心管辅助装置(LVAD)从事交易的主要公司有:Abbott, Evaheart, Inc, Saft(总能量的子公司),ABIOMED,柏林心等国内其他角色. DBMR分析师了解竞争优势,为每个竞争者分别提供竞争分析.
许多新的倡议和增加临床试验,以便获得公司发起的产品批准,正在加快左侧通风辅助装置市场。
比如说,
- 2021年3月,柏林心通过使用柏林心的EXCOR左心管辅助装置,实现了沙特阿拉伯的首次儿科心脏移植. 这种心脏移植提高了儿科年龄组的恢复率.
市场参与者的合作、产品推出、业务扩展、奖励和认可、合资企业和其他战略正在扩大公司在左口辅助设备市场中的足迹,这也为组织的利润增长提供了好处。
SKU-
目录
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF MIDDLE EAST & AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET END USER COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL
4.2 PORTER'S
4.3 INDUSTRIAL INSIGHTS:
5 MIDDLE EAST & AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: REGULATIONS
5.1 REGULATION IN U.S.
5.1.1 GUIDELINES-
5.2 REGULATION IN EUROPE
5.2.1 GUIDELINES FOR THE MANUFACTURERS:
5.3 REGULATION IN CANADA
5.3.1 GUIDELINES FOR THE MANUFACTURERS:
5.4 REGULATION IN MEXICO
5.4.1 GUIDELINES FOR THE MANUFACTURERS:
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 INCREASING GERIATRIC POPULATION ALONG WITH RISING PREVALENCE OF CARDIAC DISEASES
6.1.2 PRESENCE OF FAVOURABLE REIMBURSEMENT POLICIES
6.1.3 CHANGING LIFESTYLE TRIGGERS THE DEVELOPMENT OF CARDIOVASCULAR DISEASES
6.2 RESTRAINTS
6.2.1 HIGH COST OF LVAD IMPLANTATION AND TREATMENT
6.2.2 COMPLICATIONS AND RISKS ASSOCIATED WITH LVAD
6.3 OPPORTUNITIES
6.3.1 INCREASE IN HEALTHCARE EXPENDITURE
6.3.2 INCREASE IN MINIMALLY INVASIVE PROCEDURE
6.3.3 INCREASING SHORTAGE OF ORGAN DONORS
6.3.4 TECHNOLOGICAL ADVANCEMENTS IN LEFT VENTRICULAR ASSIST DEVICES
6.4 CHALLENGES
6.4.1 ONGOING COVID-19
6.4.2 INCREASE IN PRODUCT RECALL
7 MIDDLE EAST & AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE
7.1 OVERVIEW
7.2 HEART PUMP
7.3 CONTROLLER
7.4 BATTERIES
7.4.1 RECHARGEABLE
7.4.2 NON-RECHARGEABLE
7.5 WIRES
8 MIDDLE EAST & AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY
8.1 OVERVIEW
8.2 BRIDGE-TO-TRANSPLANT (BTT) THERAPY
8.2.1 HEART PUMP
8.2.2 CONTROLLER
8.2.3 BATTERIES
8.2.4 WIRES
8.3 DESTINATION THERAPY
8.3.1 HEART PUMP
8.3.2 CONTROLLER
8.3.3 BATTERIES
8.3.4 WIRES
8.4 BRIDGE-TO-CANDIDACY (BTC) THERAPY
8.4.1 HEART PUMP
8.4.2 CONTROLLER
8.4.3 BATTERIES
8.4.4 WIRES
8.5 BRIDGE-TO-RECOVERY (BTR) THERAPY
8.5.1 HEART PUMP
8.5.2 CONTROLLER
8.5.3 BATTERIES
8.5.4 WIRES
9 MIDDLE EAST & AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP
9.1 OVERVIEW
9.2 ADULT
9.2.1 19-39 YEARS
9.2.2 40-59 YEARS
9.2.3 60-79 YEARS
9.2.4 ABOVE 80 YEARS
9.3 PEDIATRIC
10 MIDDLE EAST & AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY GENERATION
10.1 OVERVIEW
10.2 SECOND GENERATION DEVICES
10.3 THIRD GENERATION DEVICES
10.4 FIRST GENERATION DEVICES
11 MIDDLE EAST & AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DESIGN
11.1 OVERVIEW
11.2 AXIAL
11.3 CENTRIFUGAL
12 MIDDLE EAST & AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION
12.1 OVERVIEW
12.2 CONGESTIVE HEART FAILURE
12.2.1 HEART PUMP
12.2.2 CONTROLLER
12.2.3 BATTERIES
12.2.4 WIRES
12.3 CONGENITAL HEART DISEASE
12.3.1 HEART PUMP
12.3.2 CONTROLLER
12.3.3 BATTERIES
12.3.4 WIRES
12.4 MYOCARDITIS
12.4.1 HEART PUMP
12.4.2 CONTROLLER
12.4.3 BATTERIES
12.4.4 WIRES
12.5 CARDIAC ARREST
12.5.1 HEART PUMP
12.5.2 CONTROLLER
12.5.3 BATTERIES
12.5.4 WIRES
12.6 FAMILIAL ARRHYTHMIAS AND ARRHYTHMIC CARDIOMYOPATHIES
12.6.1 HEART PUMP
12.6.2 CONTROLLER
12.6.3 BATTERIES
12.6.4 WIRES
12.7 ADVANCED HEART FAILURE
12.7.1 HEART PUMP
12.7.2 CONTROLLER
12.7.3 BATTERIES
12.7.4 WIRES
12.8 OTHERS
13 MIDDLE EAST & AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET, BY DURABILITY
13.1 OVERVIEW
13.2 LONG-TERM
13.3 INTERMEDIATE-TERM
13.4 SHORT-TERM
14 MIDDLE EAST & AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET, BY PULSE TYPE
14.1 OVERVIEW
14.2 NONPULSATILE
14.3 PULSATILE
15 MIDDLE EAST & AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET, BY END USER
15.1 OVERVIEW
15.2 HOSPITAL
15.3 CARDIAC CATH LABORATORIES
15.4 SPECIALTY CLINICS
15.5 OTHERS
16 MIDDLE EAST & AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET, BY DISTRIBUTION CHANNEL
16.1 OVERVIEW
16.2 DIRECT TENDER
16.3 RETAIL SALES
16.4 OTHERS
17 MIDDLE EAST & AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION
17.1 MIDDLE EAST & AFRICA
17.1.1 SAUDI ARABIA
17.1.2 SOUTH AFRICA
17.1.3 U.A.E.
17.1.4 EGYPT
17.1.5 ISRAEL
17.1.6 REST OF MIDDLE EAST & AFRICA
18 MIDDLE EAST & AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: COMPANY LANDSCAPE
18.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA
19 SWOT ANALYSIS
20 COMPANY PROFILE
20.1 ABIOMED
20.1.1 COMPANY SNAPSHOT
20.1.2 REVENUE ANALYSIS
20.1.3 COMPANY SHARE ANALYSIS
20.1.4 PRODUCT PORTFOLIO
20.1.5 RECENT DEVELOPMENTS
20.1.5.1 FDA APPROVAL
20.1.5.2 FDA APPROVAL
20.2 ABBOTT
20.2.1 COMPANY SNAPSHOT
20.2.2 REVENUE ANALYSIS
20.2.3 COMPANY SHARE ANALYSIS
20.2.4 PRODUCT PORTFOLIO
20.2.5 RECENT DEVELOPMENTS
20.2.5.1 SUPPLY INCREMENT
20.2.5.2 BREAK THROUGH DEVICE DESIGNATION
20.3 BERLIN HEART
20.3.1 COMPANY SNAPSHOT
20.3.2 COMPANY SHARE ANALYSIS
20.3.3 PRODUCT PORTFOLIO
20.3.4 RECENT DEVELOPMENT
20.3.4.1 PRODUCT APPROVAL
20.4 SAFT (A SUBSIDIARY OF TOTALENERGIES)
20.4.1 COMPANY SNAPSHOT
20.4.2 REVENUE ANALYSIS
20.4.3 COMPANY SHARE ANALYSIS
20.4.4 PRODUCT PORTFOLIO
20.4.5 RECENT DEVELOPMENT
20.4.5.1 PARTNERSHIP
20.5 JARVIK HEART, INC.
20.5.1 COMPANY SNAPSHOT
20.5.2 COMPANY SHARE ANALYSIS
20.5.3 PRODUCT PORTFOLIO
20.5.4 RECENT DEVELOPMENT
20.5.4.1 FDA APPROVAL
20.6 CORWAVE SA
20.6.1 COMPANY SNAPSHOT
20.6.2 PRODUCT PORTFOLIO
20.6.3 RECENT DEVELOPMENT
20.6.3.1 EXPANSION
20.7 EVAHEART, INC
20.7.1 COMPANY SNAPSHOT
20.7.2 PRODUCT PORTFOLIO
20.7.3 RECENT DEVELOPMENT
20.7.3.1 PRODUCT TRIAL
21 QUESTIONNAIRE
22 RELATED REPORTS
表格列表
TABLE 1 MIDDLE EAST & AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 2 MIDDLE EAST & AFRICA HEART PUMP IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 3 MIDDLE EAST & AFRICA CONTROLLER IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 4 MIDDLE EAST & AFRICA BATTERIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 5 MIDDLE EAST & AFRICA BATTERIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 6 MIDDLE EAST & AFRICA WIRES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 7 MIDDLE EAST & AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)
TABLE 8 MIDDLE EAST & AFRICA BRIDGE-TO-TRANSPLANT (BTT) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 9 MIDDLE EAST & AFRICA BRIDGE-TO-TRANSPLANT (BTT) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)
TABLE 10 MIDDLE EAST & AFRICA DESTINATION THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 11 MIDDLE EAST & AFRICA DESTINATION THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)
TABLE 12 MIDDLE EAST & AFRICA BRIDGE-TO-CANDIDACY (BTC) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 13 MIDDLE EAST & AFRICA BRIDGE-TO-CANDIDACY (BTC) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)
TABLE 14 MIDDLE EAST & AFRICA BRIDGE-TO-RECOVERY (BTR) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 15 MIDDLE EAST & AFRICA BRIDGE-TO-RECOVERY (BTR) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)
TABLE 16 MIDDLE EAST & AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)
TABLE 17 MIDDLE EAST & AFRICA ADULT IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 18 MIDDLE EAST & AFRICA ADULT IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)
TABLE 19 MIDDLE EAST & AFRICA PEDIATRIC IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 20 MIDDLE EAST & AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY GENERATION, 2020-2029 (USD MILLION)
TABLE 21 MIDDLE EAST & AFRICA SECOND GENERATION DEVICES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 22 MIDDLE EAST & AFRICA THIRD GENERATION DEVICES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 23 MIDDLE EAST & AFRICA FIRST GENERATION DEVICES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 24 MIDDLE EAST & AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DESIGN, 2020-2029 (USD MILLION)
TABLE 25 MIDDLE EAST & AFRICA AXIAL IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 26 MIDDLE EAST & AFRICA CENTRIFUGAL IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 27 MIDDLE EAST & AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 28 MIDDLE EAST & AFRICA CONGESTIVE HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 29 MIDDLE EAST & AFRICA CONGESTIVE HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 30 MIDDLE EAST & AFRICA CONGENITAL HEART DISEASE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 31 MIDDLE EAST & AFRICA CONGENITAL HEART DISEASE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 32 MIDDLE EAST & AFRICA MYOCARDITIS IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 33 MIDDLE EAST & AFRICA MYOCARDITIS IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 34 MIDDLE EAST & AFRICA CARDIAC ARREST IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 35 MIDDLE EAST & AFRICA CARDIAC ARREST IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 36 MIDDLE EAST & AFRICA FAMILIAL ARRHYTHYMIAS AND ARRHYTHMIC CARDIOMYOPATHIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 37 MIDDLE EAST & AFRICA FAMILIAL ARRHYTHMIAS AND ARRHYTHMIC CARDIOMYOPATHIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 38 MIDDLE EAST & AFRICA ADVANCED HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 39 MIDDLE EAST & AFRICA ADVANCED HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 40 MIDDLE EAST & AFRICA OTHERS IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 41 MIDDLE EAST & AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DURABILITY, 2020-2029 (USD MILLION)
TABLE 42 MIDDLE EAST & AFRICA LONG TERM IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 43 MIDDLE EAST & AFRICA INTERMEDIATE-TERM IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 44 MIDDLE EAST & AFRICA SHORT-TERM IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION))
TABLE 45 MIDDLE EAST & AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PULSE TYPE, 2020-2029 (USD MILLION)
TABLE 46 MIDDLE EAST & AFRICA NONPULSATILE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 47 MIDDLE EAST & AFRICA PULSATILE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 48 MIDDLE EAST & AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 49 MIDDLE EAST & AFRICA HOSPITALS IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 50 MIDDLE EAST & AFRICA CARDIAC CATH LABORATORIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 51 MIDDLE EAST & AFRICA SPECIALTY CLINICS IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 52 MIDDLE EAST & AFRICA OTHERS IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 53 MIDDLE EAST & AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 54 MIDDLE EAST & AFRICA DIRECT TENDER IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 55 MIDDLE EAST & AFRICA RETAIL SALES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 56 MIDDLE EAST & AFRICA OTHERS IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 57 MIDDLE EAST & AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY COUNTRY, 2020-2029 (USD MILLION)
TABLE 58 MIDDLE EAST & AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 59 MIDDLE EAST & AFRICA BATTERIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 60 MIDDLE EAST & AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)
TABLE 61 MIDDLE EAST & AFRICA BRIDGE-TO-TRANSPLANT (BTT) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)
TABLE 62 MIDDLE EAST & AFRICA DESTINATION THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)
TABLE 63 MIDDLE EAST & AFRICA BRIDGE-TO-CANDIDACY (BTC) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)
TABLE 64 MIDDLE EAST & AFRICA BRIDGE-TO-RECOVERY (BTR) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)
TABLE 65 MIDDLE EAST & AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)
TABLE 66 MIDDLE EAST & AFRICA ADULT IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)
TABLE 67 MIDDLE EAST & AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 68 MIDDLE EAST & AFRICA CONGESTIVE HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 69 MIDDLE EAST & AFRICA CONGENITAL HEART DISEASE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 70 MIDDLE EAST & AFRICA MYOCARDITIS IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 71 MIDDLE EAST & AFRICA CARDIAC ARREST IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 72 MIDDLE EAST & AFRICA FAMILIAL ARRHYTHYMIAS AND ARRHYTHMIC IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 73 MIDDLE EAST & AFRICA ADVANCED HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 74 MIDDLE EAST & AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY GENERATION, 2020-2029 (USD MILLION)
TABLE 75 MIDDLE EAST & AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DURABILITY, 2020-2029 (USD MILLION)
TABLE 76 MIDDLE EAST & AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DESIGN, 2020-2029 (USD MILLION)
TABLE 77 MIDDLE EAST & AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PULSE TYPE, 2020-2029 (USD MILLION)
TABLE 78 MIDDLE EAST & AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 79 MIDDLE EAST & AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 80 SAUDI ARABIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 81 SAUDI ARABIA BATTERIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 82 SAUDI ARABIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)
TABLE 83 SAUDI ARABIA BRIDGE-TO-TRANSPLANT (BTT) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)
TABLE 84 SAUDI ARABIA DESTINATION THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)
TABLE 85 SAUDI ARABIA BRIDGE-TO-CANDIDACY (BTC) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, THERAPY, 2020-2029 (USD MILLION)
TABLE 86 SAUDI ARABIA BRIDGE-TO-RECOVERY (BTR) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, THERAPY, 2020-2029 (USD MILLION)
TABLE 87 SAUDI ARABIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, AGE GROUP, 2020-2029 (USD MILLION)
TABLE 88 SAUDI ARABIA ADULT IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, AGE GROUP, 2020-2029 (USD MILLION)
TABLE 89 SAUDI ARABIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 90 SAUDI ARABIA CONGESTIVE HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 91 SAUDI ARABIA CONGENITAL HEART DISEASE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 92 SAUDI ARABIA MYOCARDITIS IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 93 SAUDI ARABIA CARDIAC ARREST IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 94 SAUDI ARABIA FAMILIAL ARRHYTHYMIAS AND ARRHYTHMIC IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 95 SAUDI ARABIA ADVANCED HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 96 SAUDI ARABIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY GENERATION, 2020-2029 (USD MILLION)
TABLE 97 SAUDI ARABIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DURABILITY, 2020-2029 (USD MILLION)
TABLE 98 SAUDI ARABIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DESIGN, 2020-2029 (USD MILLION)
TABLE 99 SAUDI ARABIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PULSE TYPE, 2020-2029 (USD MILLION)
TABLE 100 SAUDI ARABIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 101 SAUDI ARABIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 102 SOUTH AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 103 SOUTH AFRICA BATTERIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 104 SOUTH AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)
TABLE 105 SOUTH AFRICA BRIDGE-TO-TRANSPLANT (BTT) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)
TABLE 106 SOUTH AFRICA DESTINATION THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)
TABLE 107 SOUTH AFRICA BRIDGE-TO-CANDIDACY (BTC) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, THERAPY, 2020-2029 (USD MILLION)
TABLE 108 SOUTH AFRICA BRIDGE-TO-RECOVERY (BTR) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, THERAPY, 2020-2029 (USD MILLION)
TABLE 109 SOUTH AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, AGE GROUP, 2020-2029 (USD MILLION)
TABLE 110 SOUTH AFRICA ADULT IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, AGE GROUP, 2020-2029 (USD MILLION)
TABLE 111 SOUTH AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 112 SOUTH AFRICA CONGESTIVE HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 113 SOUTH AFRICA CONGENITAL HEART DISEASE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 114 SOUTH AFRICA MYOCARDITIS IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 115 SOUTH AFRICA CARDIAC ARREST IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 116 SOUTH AFRICA FAMILIAL ARRHYTHYMIAS AND ARRHYTHMIC IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 117 SOUTH AFRICA ADVANCED HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 118 SOUTH AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY GENERATION, 2020-2029 (USD MILLION)
TABLE 119 SOUTH AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DURABILITY, 2020-2029 (USD MILLION)
TABLE 120 SOUTH AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DESIGN, 2020-2029 (USD MILLION)
TABLE 121 SOUTH AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PULSE TYPE, 2020-2029 (USD MILLION)
TABLE 122 SOUTH AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 123 SOUTH AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 124 U.A.E. LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 125 U.A.E. BATTERIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 126 U.A.E. LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)
TABLE 127 U.A.E. BRIDGE-TO-TRANSPLANT (BTT) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)
TABLE 128 U.A.E. DESTINATION THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)
TABLE 129 U.A.E. BRIDGE-TO-CANDIDACY (BTC) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, THERAPY, 2020-2029 (USD MILLION)
TABLE 130 U.A.E. BRIDGE-TO-RECOVERY (BTR) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, THERAPY, 2020-2029 (USD MILLION)
TABLE 131 U.A.E. LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, AGE GROUP, 2020-2029 (USD MILLION)
TABLE 132 U.A.E. ADULT IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, AGE GROUP, 2020-2029 (USD MILLION)
TABLE 133 U.A.E. LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 134 U.A.E. CONGESTIVE HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 135 U.A.E. CONGENITAL HEART DISEASE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 136 U.A.E. MYOCARDITIS IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 137 U.A.E. CARDIAC ARREST IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 138 U.A.E. FAMILIAL ARRHYTHYMIAS AND ARRHYTHMIC IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 139 U.A.E. ADVANCED HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 140 U.A.E. LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY GENERATION, 2020-2029 (USD MILLION)
TABLE 141 U.A.E. LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DURABILITY, 2020-2029 (USD MILLION)
TABLE 142 U.A.E. LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DESIGN, 2020-2029 (USD MILLION)
TABLE 143 U.A.E. LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PULSE TYPE, 2020-2029 (USD MILLION)
TABLE 144 U.A.E. LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 145 U.A.E. LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 146 EGYPT LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 147 EGYPT BATTERIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 148 EGYPT LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)
TABLE 149 EGYPT BRIDGE-TO-TRANSPLANT (BTT) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)
TABLE 150 EGYPT DESTINATION THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)
TABLE 151 EGYPT BRIDGE-TO-CANDIDACY (BTC) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, THERAPY, 2020-2029 (USD MILLION)
TABLE 152 EGYPT BRIDGE-TO-RECOVERY (BTR) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, THERAPY, 2020-2029 (USD MILLION)
TABLE 153 EGYPT LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, AGE GROUP, 2020-2029 (USD MILLION)
TABLE 154 EGYPT ADULT IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, AGE GROUP, 2020-2029 (USD MILLION)
TABLE 155 EGYPT LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 156 EGYPT CONGESTIVE HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 157 EGYPT CONGENITAL HEART DISEASE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 158 EGYPT MYOCARDITIS IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 159 EGYPT CARDIAC ARREST IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 160 EGYPT FAMILIAL ARRHYTHYMIAS AND ARRHYTHMIC IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 161 EGYPT ADVANCED HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 162 EGYPT LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY GENERATION, 2020-2029 (USD MILLION)
TABLE 163 EGYPT LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DURABILITY, 2020-2029 (USD MILLION)
TABLE 164 EGYPT LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DESIGN, 2020-2029 (USD MILLION)
TABLE 165 EGYPT LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PULSE TYPE, 2020-2029 (USD MILLION)
TABLE 166 EGYPT LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 167 EGYPT LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 168 ISRAEL LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 169 ISRAEL BATTERIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 170 ISRAEL LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)
TABLE 171 ISRAEL BRIDGE-TO-TRANSPLANT (BTT) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)
TABLE 172 ISRAEL DESTINATION THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)
TABLE 173 ISRAEL BRIDGE-TO-CANDIDACY (BTC) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, THERAPY, 2020-2029 (USD MILLION)
TABLE 174 ISRAEL BRIDGE-TO-RECOVERY (BTR) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, THERAPY, 2020-2029 (USD MILLION)
TABLE 175 ISRAEL LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, AGE GROUP, 2020-2029 (USD MILLION)
TABLE 176 ISRAEL ADULT IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, AGE GROUP, 2020-2029 (USD MILLION)
TABLE 177 ISRAEL LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 178 ISRAEL CONGESTIVE HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 179 ISRAEL CONGENITAL HEART DISEASE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 180 ISRAEL MYOCARDITIS IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 181 ISRAEL CARDIAC ARREST IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 182 ISRAEL FAMILIAL ARRHYTHYMIAS AND ARRHYTHMIC IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 183 ISRAEL ADVANCED HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 184 ISRAEL LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY GENERATION, 2020-2029 (USD MILLION)
TABLE 185 ISRAEL LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DURABILITY, 2020-2029 (USD MILLION)
TABLE 186 ISRAEL LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DESIGN, 2020-2029 (USD MILLION)
TABLE 187 ISRAEL LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PULSE TYPE, 2020-2029 (USD MILLION)
TABLE 188 ISRAEL LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 189 ISRAEL LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 190 REST OF MIDDLE EAST & AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
图片列表
FIGURE 1 MIDDLE EAST & AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: SEGMENTATION
FIGURE 2 MIDDLE EAST & AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: DATA TRIANGULATION
FIGURE 3 MIDDLE EAST & AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: DROC ANALYSIS
FIGURE 4 MIDDLE EAST & AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: MIDDLE EAST & AFRICA VS REGIONAL ANALYSIS
FIGURE 5 MIDDLE EAST & AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 MIDDLE EAST & AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 MIDDLE EAST & AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: DBMR MARKET POSITION GRID
FIGURE 8 MIDDLE EAST & AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: END USER COVERAGE GRID
FIGURE 9 MIDDLE EAST & AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET:VENDOR SHARE ANALYSIS
FIGURE 10 MIDDLE EAST & AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: SEGMENTATION
FIGURE 11 INCREASING PREVALENCE OF CARDIOVASCULAR DISEASE AND RISING HEALTHCARE EXPENDITURE ARE EXPECTED TO DRIVE THE MIDDLE EAST & AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET IN THE FORECAST PERIOD OF 2022 TO 2029
FIGURE 12 HEART PUMP SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST & AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET IN 2022 & 2029
FIGURE 13 NORTH AMERICA IS EXPECTED TO DOMINATE THE MIDDLE EAST & AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET AND ASIA-PACIFIC TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2022 TO 2029
FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF MIDDLE EAST & AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET
FIGURE 15 MIDDLE EAST & AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY PRODUCT TYPE, 2021
FIGURE 16 MIDDLE EAST & AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY PRODUCT TYPE, 2020-2029 (USD MILLION)
FIGURE 17 MIDDLE EAST & AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY PRODUCT TYPE, CAGR (2022-2029)
FIGURE 18 MIDDLE EAST & AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 19 MIDDLE EAST & AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY THERAPY, 2021
FIGURE 20 MIDDLE EAST & AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY THERAPY, 2020-2029 (USD MILLION)
FIGURE 21 MIDDLE EAST & AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY THERAPY, CAGR (2022-2029)
FIGURE 22 MIDDLE EAST & AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY THERAPY, LIFELINE CURVE
FIGURE 23 MIDDLE EAST & AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY AGE GROUP, 2021
FIGURE 24 MIDDLE EAST & AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY AGE GROUP, 2020-2029 (USD MILLION)
FIGURE 25 MIDDLE EAST & AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY AGE GROUP, CAGR (2022-2029)
FIGURE 26 MIDDLE EAST & AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY AGE GROUP, LIFELINE CURVE
FIGURE 27 MIDDLE EAST & AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY GENERATION, 2021
FIGURE 28 MIDDLE EAST & AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY GENERATION, 2020-2029 (USD MILLION)
FIGURE 29 MIDDLE EAST & AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY GENERATION, CAGR (2022-2029)
FIGURE 30 MIDDLE EAST & AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY GENERATION, LIFELINE CURVE
FIGURE 31 MIDDLE EAST & AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY DESIGN, 2021
FIGURE 32 MIDDLE EAST & AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY DESIGN, 2020-2029 (USD MILLION)
FIGURE 33 MIDDLE EAST & AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY DESIGN, CAGR (2022-2029)
FIGURE 34 MIDDLE EAST & AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY DESIGN, LIFELINE CURVE
FIGURE 35 MIDDLE EAST & AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET: BY INDICATION, 2021
FIGURE 36 MIDDLE EAST & AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET: BY INDICATION, 2020-2029 (USD MILLION)
FIGURE 37 MIDDLE EAST & AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET: BY INDICATION, CAGR (2022-2029)
FIGURE 38 MIDDLE EAST & AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET: BY INDICATION, LIFELINE CURVE
FIGURE 39 MIDDLE EAST & AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET: BY DURABILITY, 2021
FIGURE 40 MIDDLE EAST & AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET: BY DURABILITY, 2020-2029 (USD MILLION)
FIGURE 41 MIDDLE EAST & AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET: BY DURABILITY, CAGR (2022-2029)
FIGURE 42 MIDDLE EAST & AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET: BY DURABILITY, LIFELINE CURVE
FIGURE 43 MIDDLE EAST & AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET: BY PULSE TYPE, 2021
FIGURE 44 MIDDLE EAST & AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET: BY PULSE TYPE, 2020-2029 (USD MILLION)
FIGURE 45 MIDDLE EAST & AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET: BY PULSE TYPE, CAGR (2022-2029)
FIGURE 46 MIDDLE EAST & AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET: BY PULSE TYPE, LIFELINE CURVE
FIGURE 47 MIDDLE EAST & AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET: BY END USER, 2021
FIGURE 48 MIDDLE EAST & AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET: BY END USER, 2020-2029 (USD MILLION)
FIGURE 49 MIDDLE EAST & AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET: BY END USER, CAGR (2022-2029)
FIGURE 50 MIDDLE EAST & AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET: BY END USER, LIFELINE CURVE
FIGURE 51 MIDDLE EAST & AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET: BY DISTRIBUTION CHANNEL, 2021
FIGURE 52 MIDDLE EAST & AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET: BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
FIGURE 53 MIDDLE EAST & AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET: BY DISTRIBUTION CHANNEL, CAGR (2022-2029)
FIGURE 54 MIDDLE EAST & AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 55 MIDDLE EAST & AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: SNAPSHOT (2021)
FIGURE 56 MIDDLE EAST & AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY COUNTRY (2021)
FIGURE 57 MIDDLE EAST & AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY COUNTRY (2022 & 2029)
FIGURE 58 MIDDLE EAST & AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY COUNTRY (2021 & 2029)
FIGURE 59 MIDDLE EAST & AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY PRODUCT TYPE (2022-2029)
FIGURE 60 MIDDLE EAST & AFRICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: COMPANY SHARE 2021 (%)
研究方法
数据收集和基准年分析是使用具有大样本量的数据收集模块完成的。该阶段包括通过各种来源和策略获取市场信息或相关数据。它包括提前检查和规划从过去获得的所有数据。它同样包括检查不同信息源中出现的信息不一致。使用市场统计和连贯模型分析和估计市场数据。此外，市场份额分析和关键趋势分析是市场报告中的主要成功因素。要了解更多信息，请请求分析师致电或下拉您的询问。
DBMR 研究团队使用的关键研究方法是数据三角测量，其中包括数据挖掘、数据变量对市场影响的分析和主要（行业专家）验证。数据模型包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、专利分析、定价分析、公司市场份额分析、测量标准、全球与区域和供应商份额分析。要了解有关研究方法的更多信息，请向我们的行业专家咨询。
可定制
Data Bridge Market Research 是高级形成性研究领域的领导者。我们为向现有和新客户提供符合其目标的数据和分析而感到自豪。报告可定制，包括目标品牌的价格趋势分析、了解其他国家的市场（索取国家列表）、临床试验结果数据、文献综述、翻新市场和产品基础分析。目标竞争对手的市场分析可以从基于技术的分析到市场组合策略进行分析。我们可以按照您所需的格式和数据样式添加您需要的任意数量的竞争对手数据。我们的分析师团队还可以为您提供原始 Excel 文件数据透视表（事实手册）中的数据，或者可以帮助您根据报告中的数据集创建演示文稿。
